The effectiveness of fecal microbiota transplantation in resolving diarrhea associated with C difficile infection is influenced by donor antibiotic use and stool consistency.

The ongoing trial is testing the therapy – RBX2660 – as a treatment for Clostridioides difficile infection or C. diff, a bacterium that causes diarrhoea and inflammation in the colon and is a ...

is that C. difficile is evolving to resist vancomycin. "We don't know if there are resistant strains circulating and causing human infections because hospital labs don't test for resistance to ...

The pathogen C. diff -- the most common cause of health care-associated infectious diarrhea -- can use a compound that kills the human gut's resident microbes to survive and grow, giving it a ...